Kim Daniel H, Rossi John J
Howard Hughes Medical Institute, Department of Molecular Biology, Massachusetts General Hospital and Department of Genetics, Harvard Medical School, Boston, MA, USA.
Methods Mol Biol. 2009;555:119-25. doi: 10.1007/978-1-60327-295-7_9.
RNA interference is a potent gene silencing pathway initiated by short molecules of double-stranded RNA. Small interfering RNAs (siRNAs) with full sequence complementarity to mRNAs induce cleavage of their target transcripts in the cytoplasm. Recent evidence has shown, however, that siRNAs can also function in the nucleus of mammalian cells to affect changes in chromatin structure. When targeted to promoter regions, siRNAs load into the effector protein Argonaute-1 (AGO1) and direct the formation of silent chromatin domains. This mechanism is known as transcriptional gene silencing (TGS), and the development of TGS as a novel therapeutic modality would be applicable to chronic diseases where long-term, heritable silencing of target genes is warranted. Here we discuss how small RNAs can be used to direct TGS in mammalian cells.
RNA干扰是一种由双链RNA小分子引发的强大的基因沉默途径。与信使核糖核酸(mRNA)具有完全序列互补性的小干扰RNA(siRNA)可诱导其靶转录本在细胞质中发生切割。然而,最近的证据表明,siRNA也可在哺乳动物细胞的细胞核中发挥作用,影响染色质结构的变化。当靶向启动子区域时,siRNA会加载到效应蛋白AGO1中,并指导沉默染色质结构域的形成。这种机制被称为转录基因沉默(TGS),而将TGS开发为一种新型治疗方式将适用于需要对靶基因进行长期、可遗传沉默的慢性疾病。在此,我们将讨论如何利用小RNA在哺乳动物细胞中指导TGS。